Back to Dashboard










Abbott Laboratories (ABT)
Real-time intraday values
Market Overview
From:
To:
ABT Intraday
No data available
SymbolABT
IPO DateMar 17, 1980
CEOMr. Robert B. Ford
Full Time Employees122k
SectorHealthcare
IndustryMedical Devices
CountryUnited States
ExchangeNYSE
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | +1.14% | +1.17 US$ |
| 5 Days | -1.15% | -1.21 US$ |
| 1 Month | +0.18% | +0.19 US$ |
| 6 Months | +13.77% | +12.55 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of ABT...
Key Statistics
Market Cap
179.44B
P/E Ratio
38.55
Div Yield
2.43%
52W High
$132.03
52W Low
$81.97
Analyst Consensus
ConsensusStrong Buy
Bullish2485.7%
Neutral414.3%
Bearish00.0%
52W Analyst Price Targets
Min Target
$100.00
$100.00
Max Target
$130.00
$130.00
Current$103.68
Avg Target$118.52
Analyst Recommendations
Target Price:$118.52($100.00 - $130.00)
Community Thoughts
Share your analysis and sentiment on ABT
Join the community to share your analysis
Latest News for ABT

Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?
Motley Fool•Oct 24, 2026, 05:31 PM

MarketBeat Week in Review – 10/19 - 10/23
MarketBeat•Oct 24, 2026, 11:00 AM

Abbott Laboratories (ABT) Posted Higher Sensitivity Data For Colorectal Cancer Recurrence Detection
Simply Wall St.•Oct 24, 2026, 10:13 AM
Freenome Soars 11% on Launch of Lung Cancer Blood Test That Makes Screening “Vastly Easier”
TIKR•Oct 23, 2026, 06:23 PM




Is Abbott Stock About To Rebound?
Trefis•Oct 23, 2026, 01:12 PM

3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach
MarketBeat•Oct 23, 2026, 11:25 AM

Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure Device
GlobeNewswire•Oct 22, 2026, 08:54 PM